Style | Citing Format |
---|---|
MLA | Simmons B, et al.. "Sofosbuvir/Daclatasvir Regimens for the Treatment of Covid-19: An Individual Patient Data Meta-Analysis." Journal of Antimicrobial Chemotherapy, vol. 76, no. 2, 2021, pp. 286-291. |
APA | Simmons B, Wentzel H, Mobarak S, Eslami G, Sadeghi A, Ali Asgari A, Abbaspour Kasgari H, Tirgar Fakheri H, Merat S, Hill A (2021). Sofosbuvir/Daclatasvir Regimens for the Treatment of Covid-19: An Individual Patient Data Meta-Analysis. Journal of Antimicrobial Chemotherapy, 76(2), 286-291. |
Chicago | Simmons B, Wentzel H, Mobarak S, Eslami G, Sadeghi A, Ali Asgari A, Abbaspour Kasgari H, Tirgar Fakheri H, Merat S, Hill A. "Sofosbuvir/Daclatasvir Regimens for the Treatment of Covid-19: An Individual Patient Data Meta-Analysis." Journal of Antimicrobial Chemotherapy 76, no. 2 (2021): 286-291. |
Harvard | Simmons B et al. (2021) 'Sofosbuvir/Daclatasvir Regimens for the Treatment of Covid-19: An Individual Patient Data Meta-Analysis', Journal of Antimicrobial Chemotherapy, 76(2), pp. 286-291. |
Vancouver | Simmons B, Wentzel H, Mobarak S, Eslami G, Sadeghi A, Ali Asgari A, et al.. Sofosbuvir/Daclatasvir Regimens for the Treatment of Covid-19: An Individual Patient Data Meta-Analysis. Journal of Antimicrobial Chemotherapy. 2021;76(2):286-291. |
BibTex | @article{ author = {Simmons B and Wentzel H and Mobarak S and Eslami G and Sadeghi A and Ali Asgari A and Abbaspour Kasgari H and Tirgar Fakheri H and Merat S and Hill A}, title = {Sofosbuvir/Daclatasvir Regimens for the Treatment of Covid-19: An Individual Patient Data Meta-Analysis}, journal = {Journal of Antimicrobial Chemotherapy}, volume = {76}, number = {2}, pages = {286-291}, year = {2021} } |
RIS | TY - JOUR AU - Simmons B AU - Wentzel H AU - Mobarak S AU - Eslami G AU - Sadeghi A AU - Ali Asgari A AU - Abbaspour Kasgari H AU - Tirgar Fakheri H AU - Merat S AU - Hill A TI - Sofosbuvir/Daclatasvir Regimens for the Treatment of Covid-19: An Individual Patient Data Meta-Analysis JO - Journal of Antimicrobial Chemotherapy VL - 76 IS - 2 SP - 286 EP - 291 PY - 2021 ER - |